A De Novo Deletion at 16q24.3 Involving ANKRD11 in a Japanese Patient With KBG Syndrome. Issue 5 (5th March 2013)

• Record Type: Journal Article
• Authors: Miyatake, Satoko; Murakami, Akira; Okamoto, Nobuhiko; Sakamoto, Michiko; Miyake, Noriko; Saitsu, Hirotomo; Matsumoto, Naomichi
• Is Part Of: American journal of medical genetics. Volume 161:Issue 5(2013:May)
• Page Start: 1073
• Page End: 1077
• Publication Date: 2013-03-05
• Subjects: Medical genetics -- Periodicals; 616.14205
• DOI: 10.1002/ajmg.a.35661
• Languages: English
• ISSNs: 1552-4825

Abstract

<abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <sec id="ajmga35661-sec-0001" sec-type="section"> <p>KBG syndrome is a rare autosomal dominant congenital syndrome comprising developmental delay with various neurological involvements, macrodontia of the upper central incisors, characteristic facial dysmorphism, and skeletal anomalies. <italic>ANKRD11</italic> was recently identified as the gene responsible for this syndrome. To date, there have been only five KBG syndrome families described, each carrying a single base substitution or a 1‐ to 14‐bp deletion of this gene. Here, we present a patient with clinically confirmed KBG syndrome carrying a de novo 690‐kb deletion at 16q24.3 involving part of <italic>ANKRD11</italic>. He had characteristic facial appearance, macrodontia of the upper central incisors, hand anomalies, delayed bone age and intellectual impairment without autistic features. Interestingly, the deleted region overlaps with the critical region for 16q24.3 microdeletion syndrome. We discuss the clinical entities of KBG syndrome and 16q24.3 microdeletion syndrome from a clinical and genetic point of view. © 2013 Wiley Periodicals, Inc.</p> </sec> </abstract>